AVE 33.3% 0.2¢ avecho biotechnology limited

Good news on OxyC trials next month and or a deal on Mylan...

  1. 5,322 Posts.
    Good news on OxyC trials next month and or a deal on Mylan Injectables ( which I'm hoping to see ann'd very soon) will deliver POH well into the teens if not the 20s. Ross Murdoch has got this company heading in the right direction at last- no more scientists making commercial decisions or promising the world to shareholders without the skills to deliver. Thankfully POH has turned a corner and blue skies are in view. GLTAH
 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.